Center-Authored Papers

Filters: Author is Ramalingam, Suresh S  [Clear All Filters]
Journal Article
Olszanski AJ, Smith DC, Camacho LH, Thompson J, Ramalingam SS, Harvey DR, Campos L, Ferry D, Tang S, Gao L et al..  2016.  Electrocardiographic Characterization of Ramucirumab on the Corrected QT Interval in a Phase II Study of Patients With Advanced Solid Tumors.. The oncologist. Abstract
Pang HH, Wang X, Stinchcombe TE, Wong ML, Cheng P, Ganti AK, Sargent DJ, Zhang Y, Hu C, Mandrekar SJ et al..  2016.  Enrollment Trends and Disparity Among Patients With Lung Cancer in National Clinical Trials, 1990 to 2012.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. Abstract
Herbst RS, Gandara DR, Hirsch FR, Redman MW, LeBlanc M, Mack PC, Schwartz LH, Vokes E, Ramalingam SS, Bradley JD et al..  2015.  Lung Master Protocol (Lung-MAP)-A Biomarker-Driven Protocol for Accelerating Development of Therapies for Squamous Cell Lung Cancer: SWOG S1400.. Clinical cancer research : an official journal of the American Association for Cancer Research. 21(7):1514-24. Abstract
Foster NR, Renfro LA, Schild SE, Redman MW, Wang XF, Dahlberg SE, Ding K, Bradbury PA, Ramalingam SS, Gandara DR et al..  2015.  Multitrial Evaluation of Progression-Free Survival as a Surrogate End Point for Overall Survival in First-Line Extensive-Stage Small-Cell Lung Cancer.. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer. 10(7):1099-106. Abstract
Tsao AS, Scagliotti GV, Bunn PA, Carbone DP, Warren GW, Bai C, de Koning HJ, Yousaf-Khan UA, McWilliams A, Tsao MS et al..  2016.  Scientific Advances in Lung Cancer 2015.. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer. Abstract